Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Other Accumulated Expenses (2016 - 2021)

Historic Other Accumulated Expenses for vTv Therapeutics (VTVT) over the last 8 years, with Q4 2021 value amounting to $155000.0.

  • vTv Therapeutics' Other Accumulated Expenses rose 67500.0% to $155000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $155000.0, marking a year-over-year increase of 67500.0%. This contributed to the annual value of $155000.0 for FY2021, which is 67500.0% up from last year.
  • As of Q4 2021, vTv Therapeutics' Other Accumulated Expenses stood at $155000.0, which was up 67500.0% from $20000.0 recorded in Q4 2020.
  • vTv Therapeutics' Other Accumulated Expenses' 5-year high stood at $1.1 million during Q4 2017, with a 5-year trough of $20000.0 in Q4 2020.
  • For the 5-year period, vTv Therapeutics' Other Accumulated Expenses averaged around $300400.0, with its median value being $142000.0 (2018).
  • In the last 5 years, vTv Therapeutics' Other Accumulated Expenses tumbled by 8655.3% in 2018 and then skyrocketed by 67500.0% in 2021.
  • Over the past 5 years, vTv Therapeutics' Other Accumulated Expenses (Quarter) stood at $1.1 million in 2017, then tumbled by 86.55% to $142000.0 in 2018, then dropped by 9.15% to $129000.0 in 2019, then plummeted by 84.5% to $20000.0 in 2020, then surged by 675.0% to $155000.0 in 2021.
  • Its Other Accumulated Expenses stands at $155000.0 for Q4 2021, versus $20000.0 for Q4 2020 and $129000.0 for Q4 2019.